name,category,termsAE binding protein 1,INTERPRO[450000360$IPR000421:Coagulation factor 5/8 type, C-terminal, 450000726$IPR000834:Peptidase M14, carboxypeptidase A, 450013216$IPR014766:Carboxypeptidase, regulatory region]
AE binding protein 1,SMART[760000203$SM00231:FA58C, 760000546$SM00631:Zn_pept]
AE binding protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000616$glycoprotein, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001363$Secreted, 790001405$signal, 790001539$Transcription, 790001543$transcription regulation]
AE binding protein 1,UP_SEQ_FEATURE[850003958$chain:Adipocyte enhancer-binding protein 1, 850102507$compositionally biased region:Glu-rich, 850102586$compositionally biased region:Pro-rich, 850103733$domain:F5/8 type C, 850105770$glycosylation site:N-linked (GlcNAc...), 850112511$region of interest:Interaction with MAPK1 and MAPK3, 850112725$region of interest:Interaction with PTEN, 850114290$region of interest:Required for DNA-binding and interaction with NFKBIA, 850114500$region of interest:Required for transcriptional repression, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
ClpB caseinolytic peptidase B homolog (E. coli),INTERPRO[450001121$IPR001270:Chaperonin clpA/B, 450001870$IPR002110:Ankyrin, 450003154$IPR003593:ATPase, AAA+ type, core, 450011737$IPR013093:ATPase associated with various cellular activities, AAA-2, 450017726$IPR019489:Clp ATPase, C-terminal]
ClpB caseinolytic peptidase B homolog (E. coli),SMART[760000220$SM00248:ANK, 760000335$SM00382:AAA]
ClpB caseinolytic peptidase B homolog (E. coli),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000138$atp-binding, 790000356$complete proteome, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat]
ClpB caseinolytic peptidase B homolog (E. coli),UP_SEQ_FEATURE[850009796$chain:Caseinolytic peptidase B protein homolog, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117295$sequence variant, 850118574$splice variant]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,INTERPRO[450001490$IPR001680:WD40 repeat, 450001603$IPR001810:Cyclin-like F-box, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,SMART[760000228$SM00256:FBOX, 760000289$SM00320:WD40]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
F-box and WD repeat domain containing 10; similar to FBXW10 protein,UP_SEQ_FEATURE[850018845$chain:F-box/WD repeat-containing protein 10, 850103725$domain:F-box, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Kv channel interacting protein 2,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Kv channel interacting protein 2,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
Kv channel interacting protein 2,SMART[760000046$SM00054:EFh]
Kv channel interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001304$repeat, 790001558$transport, 790001631$voltage-gated channel]
Kv channel interacting protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850027659$chain:Kv channel-interacting protein 2, 850103582$domain:EF-hand 1; degenerate, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112463$region of interest:Interaction with KCND2, 850117294$sequence conflict, 850118574$splice variant]
RUN and FYVE domain containing 3,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
RUN and FYVE domain containing 3,INTERPRO[450003532$IPR004012:RUN]
RUN and FYVE domain containing 3,SMART[760000527$SM00593:RUN]
RUN and FYVE domain containing 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001016$neurogenesis, 790001162$phosphoprotein]
RUN and FYVE domain containing 3,UP_SEQ_FEATURE[850047544$chain:Protein RUFY3, 850105223$domain:RUN, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
SIX homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
SIX homeobox 1,OMIM_DISEASE[520000656$Brachiootic syndrome 3, 520001326$Deafness, autosomal dominant 23]
SIX homeobox 1,SMART[760000341$SM00389:HOX]
SIX homeobox 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000415$deafness, 790000428$developmental protein, 790000446$disease mutation, 790000466$dna-binding, 790000699$Homeobox, 790001041$non-syndromic deafness, 790001065$nucleus]
SIX homeobox 1,UP_SEQ_FEATURE[850024663$chain:Homeobox protein SIX1, 850102927$DNA-binding region:Homeobox, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 12 open reading frame 40; chromosome 12 open reading frame 4,INTERPRO[450017549$IPR019311:Protein of unknown function DUF2362]
chromosome 12 open reading frame 40; chromosome 12 open reading frame 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 12 open reading frame 40; chromosome 12 open reading frame 4,UP_SEQ_FEATURE[850073044$chain:Uncharacterized protein C12orf4, 850073046$chain:Uncharacterized protein C12orf40, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 22 open reading frame 43,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 22 open reading frame 43,UP_SEQ_FEATURE[850055287$chain:Putative uncharacterized protein C22orf43, 850102458$compositionally biased region:Asp-rich, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 6 open reading frame 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
chromosome 6 open reading frame 1,UP_SEQ_FEATURE[850074321$chain:Uncharacterized protein C6orf1, 850117295$sequence variant, 850117814$signal peptide]
chromosome 9 open reading frame 72,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 72,UP_SEQ_FEATURE[850074556$chain:Uncharacterized protein C9orf72, 850117295$sequence variant, 850118574$splice variant]
coatomer protein complex, subunit zeta 1,INTERPRO[450000697$IPR000804:Clathrin adaptor, sigma subunit/coatomer, zeta subunit]
coatomer protein complex, subunit zeta 1,PIR_SUPERFAMILY[630012713$PIRSF015943:vesicle coat complex COPI, zeta subunit]
coatomer protein complex, subunit zeta 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
coatomer protein complex, subunit zeta 1,UP_SEQ_FEATURE[850011806$chain:Coatomer subunit zeta-1, 850105852$helix, 850106258$modified residue, 850118575$strand]
coiled-coil domain containing 97,INTERPRO[450016885$IPR018613:Protein of unknown function DUF2052, coiled-coil]
coiled-coil domain containing 97,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein]
coiled-coil domain containing 97,UP_SEQ_FEATURE[850012079$chain:Coiled-coil domain-containing protein 97, 850106258$modified residue]
complement component 1, q subcomponent, B chain,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
complement component 1, q subcomponent, B chain,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038895$hsa05020:Prion diseases, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 1, q subcomponent, B chain,OMIM_DISEASE[520000717$C1q deficiency, type B]
complement component 1, q subcomponent, B chain,PIR_SUPERFAMILY[630002593$PIRSF002477:complement subcomponent C1q chain A]
complement component 1, q subcomponent, B chain,SMART[760000097$SM00110:C1Q]
complement component 1, q subcomponent, B chain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000345$collagen, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000679$heterodimer, 790000745$hydroxylation, 790000746$hydroxylysine, 790000747$hydroxyproline, 790000763$immune response, 790000777$innate immunity, 790001191$plasma, 790001212$polymorphism, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001568$triple helix]
complement component 1, q subcomponent, B chain,UP_SEQ_FEATURE[850012305$chain:Complement C1q subcomponent subunit B, 850102883$disulfide bond, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105818$glycosylation site:O-linked (Gal...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
exportin 7,COG_ONTOLOGY[90000088$Nuclear structure / Intracellular trafficking and secretion]
exportin 7,INTERPRO[450001329$IPR001494:Importin-beta, N-terminal]
exportin 7,PIR_SUPERFAMILY[630009518$PIRSF010822:Exportin]
exportin 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001554$translocation, 790001558$transport]
exportin 7,UP_SEQ_FEATURE[850018365$chain:Exportin-7, 850104418$domain:Importin N-terminal, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
forkhead box P3,INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450006475$IPR007087:Zinc finger, C2H2-type, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box P3,OMIM_DISEASE[520001516$Diabetes mellitus, type I, susceptibility to, 520002620$Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked]
forkhead box P3,SMART[760000307$SM00339:FH, 760000323$SM00355:ZnF_C2H2]
forkhead box P3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000430$diabetes mellitus, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
forkhead box P3,UP_SEQ_FEATURE[850019897$chain:Forkhead box protein P3, 850102914$DNA-binding region:Fork-head, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10, 450015496$IPR017176:Alpha-(1, 3)-fucosyltransferase, metazoan]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),PIR_SUPERFAMILY[630028882$PIRSF037332:Alpha1_3FUT_met]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 10 (alpha (1,3) fucosyltransferase),UP_SEQ_FEATURE[850004582$chain:Alpha-(1,3)-fucosyltransferase 10, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
glycerol-3-phosphate dehydrogenase 1-like,INTERPRO[450005542$IPR006109:NAD-dependent glycerol-3-phosphate dehydrogenase, C-terminal, 450005600$IPR006168:NAD-dependent glycerol-3-phosphate dehydrogenase, 450010068$IPR011128:NAD-dependent glycerol-3-phosphate dehydrogenase, N-terminal, 450011961$IPR013328:Dehydrogenase, multihelical, 450014426$IPR016040:NAD(P)-binding domain, 450016074$IPR017751:NAD-dependent glycerol-3-phosphate dehydrogenase, eukaryotic]
glycerol-3-phosphate dehydrogenase 1-like,KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism]
glycerol-3-phosphate dehydrogenase 1-like,OMIM_DISEASE[520000703$Brugada syndrome 2]
glycerol-3-phosphate dehydrogenase 1-like,PIR_SUPERFAMILY[630000135$PIRSF000114:glycerol-3-phosphate dehydrogenase (NAD), 630000136$PIRSF000114:Glycerol-3-P_dh]
glycerol-3-phosphate dehydrogenase 1-like,SP_PIR_KEYWORDS[790000002$3d-structure, 790000207$Brugada syndrome, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
glycerol-3-phosphate dehydrogenase 1-like,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000454$binding site:NAD, 850000458$binding site:NAD; via amide nitrogen, 850000555$binding site:Substrate, 850021923$chain:Glycerol-3-phosphate dehydrogenase 1-like protein, 850105852$helix, 850106301$nucleotide phosphate-binding region:NAD, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
harbinger transposase derived 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790001049$nuclease, 790001065$nucleus]
harbinger transposase derived 1,UP_SEQ_FEATURE[850052941$chain:Putative nuclease HARBI1, 850105986$metal ion-binding site:Divalent metal cation]
isocitrate dehydrogenase 1 (NADP+), soluble,INTERPRO[450001597$IPR001804:Isocitrate/isopropylmalate dehydrogenase, 450004276$IPR004790:Isocitrate dehydrogenase NADP-dependent, eukaryotic, 450018049$IPR019818:Isocitrate/isopropylmalate dehydrogenase, conserved site]
isocitrate dehydrogenase 1 (NADP+), soluble,KEGG_PATHWAY[470038726$hsa00020:Citrate cycle (TCA cycle), 470038764$hsa00480:Glutathione metabolism]
isocitrate dehydrogenase 1 (NADP+), soluble,PIR_SUPERFAMILY[630000125$PIRSF000108:IDH_NADP, 630000126$PIRSF000108:isocitrate dehydrogenase (NADP)]
isocitrate dehydrogenase 1 (NADP+), soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000620$glyoxylate bypass, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding, 790001008$nadp, 790001092$oxidoreductase, 790001128$peroxisome, 790001212$polymorphism, 790001564$tricarboxylic acid cycle]
isocitrate dehydrogenase 1 (NADP+), soluble,UP_SEQ_FEATURE[850000461$binding site:NADP, 850000464$binding site:NADP; via amide nitrogen and carbonyl oxygen, 850000555$binding site:Substrate, 850026872$chain:Isocitrate dehydrogenase [NADP] cytoplasmic, 850105852$helix, 850106148$metal ion-binding site:Magnesium or manganese, 850106258$modified residue, 850106307$nucleotide phosphate-binding region:NADP, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850117295$sequence variant, 850118162$site:Critical for catalysis, 850118575$strand, 850118624$turn]
polymerase (DNA directed) kappa,INTERPRO[450000987$IPR001126:DNA-repair protein, UmuC-like, 450006060$IPR006642:Zinc finger, Rad18-type putative, 450016272$IPR017963:DNA-repair protein, UmuC-like, N-terminal]
polymerase (DNA directed) kappa,SMART[760000640$SM00734:ZnF_Rad18]
polymerase (DNA directed) kappa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790000460$dna replication, 790000465$dna synthesis, 790000466$dna-binding, 790000467$dna-directed dna polymerase, 790000899$magnesium, 790000937$metal-binding, 790000999$mutator protein, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001357$Schiff base, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
polymerase (DNA directed) kappa,UP_SEQ_FEATURE[850015664$chain:DNA polymerase kappa, 850105608$domain:UmuC, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118898$zinc finger region:Rad18-type 1, 850118899$zinc finger region:Rad18-type 2]
pyruvate dehydrogenase kinase, isozyme 2,BBID[10000007$104.Insulin_signaling, 10000008$105.Signaling_glucose_uptake, 10000009$106.Glycogen_synthase-synthesis, 10000010$107.mRNA_translation-protein_synthesis]
pyruvate dehydrogenase kinase, isozyme 2,BIOCARTA[30000095$h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase, 30000146$h_igf1mtorpathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway, 30000195$h_mTORPathway:mTOR Signaling Pathway, 30000243$h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis]
pyruvate dehydrogenase kinase, isozyme 2,INTERPRO[450003155$IPR003594:ATP-binding region, ATPase-like, 450004926$IPR005467:Signal transduction histidine kinase, core, 450017225$IPR018955:Branched-chain alpha-ketoacid dehydrogenase kinase/Pyruvate dehydrogenase kinase, mitochondrial]
pyruvate dehydrogenase kinase, isozyme 2,PIR_SUPERFAMILY[630000828$PIRSF000718:branched-chain alpha-keto acid dehydrogenase kinase]
pyruvate dehydrogenase kinase, isozyme 2,SMART[760000339$SM00387:HATPase_c]
pyruvate dehydrogenase kinase, isozyme 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000138$atp-binding, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000596$glucose metabolism, 790000825$kinase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001168$phosphotransferase, 790001212$polymorphism, 790001547$transferase, 790001550$transit peptide]
pyruvate dehydrogenase kinase, isozyme 2,UP_SEQ_FEATURE[850000242$binding site:ATP, 850102374$chain:[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial, 850104129$domain:Histidine kinase, 850105852$helix, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
regulator of G protein signaling 9 binding protein,OMIM_DISEASE[520000668$Bradyopsia]
regulator of G protein signaling 9 binding protein,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001377$sensory transduction, 790001408$Signal transduction inhibitor, 790001555$transmembrane, 790001622$vision]
regulator of G protein signaling 9 binding protein,UP_SEQ_FEATURE[850057042$chain:Regulator of G-protein signaling 9- binding protein, 850114678$region of interest:SNARE-like, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
serum amyloid A4, constitutive,INTERPRO[450000080$IPR000096:Serum amyloid A protein]
serum amyloid A4, constitutive,PIR_SUPERFAMILY[630002587$PIRSF002472:amyloid protein, SAA type, 630002588$PIRSF002472:Serum_amyloid_A]
serum amyloid A4, constitutive,SMART[760000170$SM00197:SAA]
serum amyloid A4, constitutive,SP_PIR_KEYWORDS[790000022$acute phase, 790000077$amyloid, 790000356$complete proteome, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000643$hdl, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
serum amyloid A4, constitutive,UP_SEQ_FEATURE[850060418$chain:Serum amyloid A-4 protein, 850105806$glycosylation site:N-linked (GlcNAc...); partial, 850117295$sequence variant, 850117814$signal peptide]
sine oculis binding protein homolog (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
sine oculis binding protein homolog (Drosophila),UP_SEQ_FEATURE[850060846$chain:Sine oculis-binding protein homolog, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118808$zinc finger region:FCS-type 1, 850118809$zinc finger region:FCS-type 2]
sorting nexin 10,INTERPRO[450001492$IPR001683:Phox-like]
sorting nexin 10,PIR_SUPERFAMILY[630013978$PIRSF017212:sorting nexin, Snx3 type]
sorting nexin 10,SMART[760000282$SM00312:PX]
sorting nexin 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
sorting nexin 10,UP_SEQ_FEATURE[850061537$chain:Sorting nexin-10, 850105129$domain:PX, 850117295$sequence variant]
synaptotagmin binding, cytoplasmic RNA interacting protein,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450005958$IPR006535:HnRNP R and Q splicing factor, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
synaptotagmin binding, cytoplasmic RNA interacting protein,SMART[760000328$SM00360:RRM]
synaptotagmin binding, cytoplasmic RNA interacting protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000733$host-virus interaction, 790000811$isopeptide bond, 790000959$microsome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001433$Spliceosome, 790001592$ubl conjugation, 790001613$viral nucleoprotein]
synaptotagmin binding, cytoplasmic RNA interacting protein,UP_SEQ_FEATURE[850023595$chain:Heterogeneous nuclear ribonucleoprotein Q, 850102584$compositionally biased region:Poly-Tyr, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850110233$region of interest:3 X 4 AA repeats of Y-Y-G-Y, 850110707$region of interest:8 X 3 AA repeats of R-G-G, 850112083$region of interest:Interaction with APOBEC1, 850112849$region of interest:Interaction with SMN, 850115075$repeat:1-1, 850115091$repeat:1-2, 850115103$repeat:1-3, 850115113$repeat:1-4, 850115116$repeat:1-5, 850115119$repeat:1-6, 850115122$repeat:1-7, 850115124$repeat:1-8, 850115274$repeat:2-1, 850115291$repeat:2-2, 850115306$repeat:2-3, 850117294$sequence conflict, 850117325$short sequence motif:Bipartite nuclear localization signal, 850118574$splice variant, 850118575$strand]
terminal uridylyl transferase 1, U6 snRNA-specific,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450001823$IPR002058:PAP/25A-associated, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014303$IPR015880:Zinc finger, C2H2-like]
terminal uridylyl transferase 1, U6 snRNA-specific,SMART[760000323$SM00355:ZnF_C2H2, 760000328$SM00360:RRM]
terminal uridylyl transferase 1, U6 snRNA-specific,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001547$transferase]
terminal uridylyl transferase 1, U6 snRNA-specific,UP_SEQ_FEATURE[850067883$chain:U6 snRNA-specific terminal uridylyltransferase 1, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
transcription elongation factor A (SII), 2,INTERPRO[450001075$IPR001222:Zinc finger, TFIIS-type, 450003177$IPR003617:Transcription elongation factor, TFIIS/CRSP70, N-terminal, sub-type, 450003178$IPR003618:Transcription elongation factor S-II, central region, 450005714$IPR006289:Transcription elongation factor, TFIIS, 450009997$IPR010990:Transcription elongation factor, TFIIS/elongin A/CRSP70, N-terminal, 450013215$IPR014765:Transcription elongation factor, TFIIS/CRSP70, N-terminal, 450014813$IPR016492:Transcription elongation factor, IIS, 450016205$IPR017890:Transcription elongation factor S-IIM, 450016237$IPR017923:TFIIS N-terminal]
transcription elongation factor A (SII), 2,PIR_SUPERFAMILY[630006663$PIRSF006704:TF_IIS, 630006664$PIRSF006704:transcription elongation factor, IIS type]
transcription elongation factor A (SII), 2,SMART[760000386$SM00440:ZnF_C2C2, 760000452$SM00509:TFS2N, 760000453$SM00510:TFS2M]
transcription elongation factor A (SII), 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000491$elongation factor, 790000811$isopeptide bond, 790000892$lymphocyte, 790000937$metal-binding, 790001065$nucleus, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
transcription elongation factor A (SII), 2,UP_SEQ_FEATURE[850064947$chain:Transcription elongation factor A protein 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105476$domain:TFIIS central, 850105477$domain:TFIIS N-terminal, 850118934$zinc finger region:TFIIS-type]
transmembrane protein 186,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
transmembrane protein 186,UP_SEQ_FEATURE[850066109$chain:Transmembrane protein 186, 850117294$sequence conflict, 850118623$transmembrane region]
triggering receptor expressed on myeloid cells-like 1,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
triggering receptor expressed on myeloid cells-like 1,SMART[760000357$SM00409:IG]
triggering receptor expressed on myeloid cells-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000447$disulfide bond, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001555$transmembrane]
triggering receptor expressed on myeloid cells-like 1,UP_SEQ_FEATURE[850066528$chain:Trem-like transcript 1 protein, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850104407$domain:Ig-like V-type, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850117518$short sequence motif:ITIM, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
urocortin 2,INTERPRO[450000159$IPR000187:Corticotropin-releasing factor, CRF]
urocortin 2,SMART[760000031$SM00039:CRF]
urocortin 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000708$hormone, 790001363$Secreted, 790001405$signal]
urocortin 2,UP_SEQ_FEATURE[850099655$chain:Urocortin-2, 850105852$helix, 850117814$signal peptide]
zinc finger protein 625,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 625,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 625,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 625,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 625,UP_SEQ_FEATURE[850101806$chain:Zinc finger protein 625, 850117295$sequence variant, 850118686$zinc finger region:C2H2-type 1; degenerate, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
